Table 2. Summary of cardiovascular adverse effects related to rituximab treatment .

Cardiovascular adverse effects related to rituximab treatment

Hypotension

Cardiogenic shock

ACS (angina, unstable angina and myocardial infarction)

Arrhythmia (monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, supraventricular tachycardia, trigeminy, bradycardia, atrial fibrillation and nonspecific dysrhythmias or tachycardia)

Reduction in LVEF (may occur within the first few hours after the initial infusion dose or after subsequent doses)

Non-ischemic Cardiomyopathy

Takotsubo’s cardiomyopathy